Takafumi Nakao, Noriko Yoshida, Takahiko Nakane, Yoshiki Terada, Hirohisa Nakamae, Ki-Ryang Koh, Takahisa Yamane, Masayuki Hino
Index: Rinsho. Ketsueki. 52(5) , 278-81, (2011)
Full Text: HTML
We describe a patient with chronic myelogenous leukemia (CML) who developed drug-induced agranulocytosis. A 75-year-old female was diagnosed with CML in December 2001. She had been receiving imatinib therapy for more than five years. In August 2007, she was hospitalized due to a severe neutropenia 10 days after colonoscopy. She was diagnosed as having agranulocytosis induced by colonoscopy premedication including scopolamine butylbromide and flumazenil. Severe neutropenia was resolved by G-CSF treatment without CML progression. Agranulocytosis in patients with CML is rare, but potentially lethal. Here, we report the clinical course in this patient.
| Structure | Name/CAS No. | Molecular Formula | Articles |
|---|---|---|---|
![]() |
Scopolamine butylbromide
CAS:149-64-4 |
C21H30BrNO4 |
|
Chemical genetics reveals a complex functional ground state ...
2007-05-01 [Nat. Chem. Biol. 3(5) , 268-273, (2007)] |
|
Small intestinal contrast ultrasonography for the detection ...
2015-01-01 [J. Gastroenterol. Hepatol. 30(1) , 86-91, (2014)] |
|
Lymphoid nodular hyperplasia of the terminal ileum can mimic...
2014-10-01 [AJR Am. J. Roentgenol. 203(4) , W400-7, (2014)] |
|
Hyoscine butylbromide: a review of its use in the treatment ...
2007-01-01 [Drugs 67(9) , 1343-57, (2007)] |
|
Colonic distention at CT colonography: randomized evaluation...
2015-01-01 [AJR Am. J. Roentgenol. 204(1) , 76-82, (2015)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved
